Last Updated: September 23, 2026

Mikart Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MIKART

MIKART has forty-three approved drugs.

Summary for Mikart

US Patents:	0
Tradenames:	12
Ingredients:	11
NDAs:	43

Drugs and US Patents for Mikart

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mikart	ACETAMINOPHEN AND CODEINE PHOSPHATE	acetaminophen; codeine phosphate	TABLET;ORAL	089231-001	Mar 3, 1986		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mikart	ACETAMINOPHEN AND CODEINE PHOSPHATE	acetaminophen; codeine phosphate	TABLET;ORAL	089244-001	Feb 25, 1986		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mikart	ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE	acetaminophen; aspirin; codeine phosphate	CAPSULE;ORAL	081096-001	Oct 26, 1990		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mikart	ESGIC-PLUS	acetaminophen; butalbital; caffeine	TABLET;ORAL	089451-001	May 23, 1988		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mikart	METHOCARBAMOL	methocarbamol	TABLET;ORAL	212707-001	Jun 12, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Mikart	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	acetaminophen; butalbital; caffeine	TABLET;ORAL	040496-001	Dec 23, 2003		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Mikart	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	SOLUTION;ORAL	081051-001	Aug 28, 1992		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Mikart

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.